Sinocare Inc
SZSE:300298

Watchlist Manager
Sinocare Inc Logo
Sinocare Inc
SZSE:300298
Watchlist
Price: 23.29 CNY -5.56% Market Closed
Market Cap: 12.9B CNY
Have any thoughts about
Sinocare Inc?
Write Note

Sinocare Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sinocare Inc
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Sinocare Inc
SZSE:300298
Additional Paid In Capital
ÂĄ1.1B
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
8%
A
APT Medical Inc
SSE:688617
Additional Paid In Capital
ÂĄ724m
CAGR 3-Years
66%
CAGR 5-Years
46%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Additional Paid In Capital
ÂĄ2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
40%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Additional Paid In Capital
ÂĄ6.9B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Additional Paid In Capital
ÂĄ711.8m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Additional Paid In Capital
ÂĄ13.9B
CAGR 3-Years
64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sinocare Inc
Glance View

Market Cap
13.1B CNY
Industry
Health Care

Sinocare, Inc. engages in the research, development, manufacture, and commercialization of biosensor-based blood glucose monitoring systems. The company is headquartered in Changsha, Hunan and currently employs 3,534 full-time employees. The company went IPO on 2012-03-19. The firm mainly provides micro blood instant blood sugar monitoring systems including blood sugar testing instruments and related blood sugar testing strips, as well as blood sugar testing systems and mobile blood sugar instruments, among others. The firm also provides diabetes management information systems. The company distributes its products within domestic market and to overseas markets under the brand name of SANNUO.

Intrinsic Value
36.62 CNY
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Sinocare Inc's Additional Paid In Capital?
Additional Paid In Capital
1.1B CNY

Based on the financial report for Jun 30, 2024, Sinocare Inc's Additional Paid In Capital amounts to 1.1B CNY.

What is Sinocare Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
8%

Over the last year, the Additional Paid In Capital growth was 1%. The average annual Additional Paid In Capital growth rates for Sinocare Inc have been -4% over the past three years , -2% over the past five years , and 8% over the past ten years .

Back to Top